Join us in our second episode as we explore the world of biotechnology with an expert who brings over two decades of experience in the biopharmaceutical industry: Klaus Graumann . Armed with a PhD in Biotechnology, he embarked on an incredible journey that led him to depart from the corridors of Big Pharma in 2018 and transition into the entrepreneurial realm, becoming the Biotech Consultant and CEO at Phoenestra GmbH.

In this exclusive interview, Klaus Graumann shares his profound insights, gained through years of industry expertise, and his bold venture in steering Phoenestra towards pioneering platform technologies focused on the development of stem cell-derived products. Join us as we uncover the innovative pathways and visionary strategies fueling the future of biotech through the lens of his expertise and entrepreneurial acumen.

Further links to our guest's profiles:

Phoenestra

Klaus Graumann's LinkedIn Profile

---

Let us know if you like our work by following us on LinkedIn, signing up for our bi-weekly Inside AI in Life Science Newsletter, or subscribing to our podcast on a relevant platform for you.

---

Other podcast platforms:

Google Podcasts

Spotify

YouTube

---

Hosts:

Elisa Opriessnig and Benjamin Obexer

---

Image analysis and AI application training IKOSA platform app.ikosa.ai

---

Social media:

Facebook and Twitter

---

https://www.kmlvision.com/

[email protected]

KML Vision GmbH

Nikolaiplatz 4, 2nd floor

Graz Austria

---

Music attributions:

https://pixabay.com/music/beats-jazzy-abstract-beat-11254/

Hosted on Acast. See acast.com/privacy for more information.